Concepedia

Christina Dickson

CD

10

Publications

1.3K

Citations

10

H-Index

2016

Active since

Affiliations

Eli Lilly (United States)(Current)

Keio University

Medical University of Vienna

Tokyo Women's Medical University

NIHR Leeds Musculoskeletal Biomedical Research Unit

Christina Dickson is an author at Eli Lilly (United States) specializing in clinical trials, systemic lupus erythematosus, and systemic lupus erythematosus treatment.

Top concepts

Publications per year

2016–2023

10

Publications

10

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment

Roy Fleischmann, Michael Schiff, Désirée van der Heijde et al. · Arthritis & Rheumatology · 2016 · 396 citations · Full text

Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment

Josef S Smolen, Mark C. Genovese, Tsutomu Takeuchi et al. · The Journal of Rheumatology · 2018 · 251 citations · Full text

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Michelle Petri, Ian N Bruce, Thomas Dörner et al. · The Lancet · 2023 · 150 citations

, , +8

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

Eric F. Morand, Edward M Vital, Michelle Petri et al. · The Lancet · 2023 · 133 citations

, , +9

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

Kevin Winthrop, Masayoshi Harigai, Mark C. Genovese et al. · Annals of the Rheumatic Diseases · 2020 · 89 citations · Full text

Rows per page

1–5 of 10